Chronic myeloid leukemia: proving ground for cancer stem cells
- PMID: 15507204
- DOI: 10.1016/j.cell.2004.10.015
Chronic myeloid leukemia: proving ground for cancer stem cells
Abstract
A central question in cancer biology is whether malignancy arises in self-renewing tissue stem cells that suffer oncogene activation or in differentiated cells that acquire properties of unremitting self-renewal? In two papers, Weissman and colleagues document both mechanisms: chronic leukemia arising by mutation affecting the hematopoietic stem cell (HSC) and acute leukemia evolving from committed granulocyte-macrophage progenitors that have acquired the self-renewal machinery of HSCs.
Comment on
-
JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.Cell. 2004 Oct 29;119(3):431-43. doi: 10.1016/j.cell.2004.10.010. Cell. 2004. PMID: 15507213
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical